Cellosaurus A549 EML4-ALK-Luc2 (CVCL_VR66)
| Cell line name | A549 EML4-ALK-Luc2 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | EML4-ALK Fusion-A549 Isogenic-Luc2 | ||||||||||||||||||
| Accession | CVCL_VR66 | ||||||||||||||||||
| Resource Identification Initiative | To cite this cell line use: A549 EML4-ALK-Luc2 (RRID:CVCL_VR66) | ||||||||||||||||||
| Comments | Population: Caucasian. Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter. Doubling time: ~23 hours (ATCC=CCL-185IG-LUC2). Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression). Transfected with: UniProtKB; P33967; B.cereus Bsr. Derived from site: In situ; Lung; UBERON=UBERON_0002048. | ||||||||||||||||||
| Sequence variations |
| ||||||||||||||||||
| Disease | Lung adenocarcinoma (NCIt: C3512) | ||||||||||||||||||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||
| Hierarchy | Parent: CVCL_JK07 (A549 EML4-ALK) | ||||||||||||||||||
| Sex of cell | Male | ||||||||||||||||||
| Age at sampling | 58Y | ||||||||||||||||||
| Category | Cancer cell line | ||||||||||||||||||
| STR profile | Source(s): ATCC=CCL-185IG-LUC2 Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
| Cross-references | |||||||||||||||||||
| Cell line collections (Providers) | ATCC; CCL-185IG-LUC2 | ||||||||||||||||||
| Cell line databases/resources | cancercelllines; CVCL_VR66 | ||||||||||||||||||
| Encyclopedic resources | Wikidata; Q93311901 | ||||||||||||||||||
| Entry history | |||||||||||||||||||
| Entry creation | 25-Feb-2019 | ||||||||||||||||||
| Last entry update | 02-May-2024 | ||||||||||||||||||
| Version number | 8 | ||||||||||||||||||